The funding supports a wide variety of mental health and addiction initiatives, ranging from youth suicide prevention to drug ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video, Jonathan A. Bernstein, MD, discusses his American College of Allergy, Asthma & ...

"This milestone is both a personal blessing and a testimony to the remarkable advances that have been made in cancer care in recent years," the monarch said Tommy Forbes/Bango Studios/Getty King ...

Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior CDK4/6 inhibitor therapy. The rAMBER study highlights Verzenio's potential ...

Work has halted on Wichita’s new $574M water plant after repeated equipment failures Wichita Water Partners will hire a third‑party inspector to diagnose the problem City delays plant acceptance and ...

A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven in 10—are not receiving access to potentially life-saving drugs within six ...

Blood clots can be dangerous and even life-threatening. When a clot forms in a deep vein or travels to the lungs, doctors usually prescribe anti-clotting drugs, also known as anticoagulants, to ...

(WXYZ) — In today’s Health Alert, a new type of diabetes was recognized earlier this year. It’s called Type 5 and affects 20 to 25 million people around the ...

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds ...

To date, only seven people worldwide have been considered cured of HIV infection. Now, a study from the Federal University of São Paulo (UNIFESP), published in August, has reignited hope by achieving ...

FillPoint Health, a Lyceum Health company and URAC/ACHC-accredited specialty pharmacy and MSO, announced today a strategic partnership with Noble, an Aptar Pharma company and global leader in drug ...

An unlikely, decades-old drug is gaining traction as a promising off-label treatment for fibromyalgia, driven by a handful of studies and a growing number of anecdotal reports. Low-dose naltrexone ...